Products

AIRAscore
AIRAmed
Neurology AI
AI-powered software for quantitative brain volumetry from MRI scans to aid in the early and differential diagnosis of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Multiple Sclerosis.

See all 1 product →

About AIRAmed

AIRAmed is a medical technology company specializing in quantitative neuroradiology, leveraging artificial intelligence (AI) to enhance the diagnosis and monitoring of neurodegenerative diseases. Their flagship software, AIRAscore, analyzes magnetic resonance (MR) image data to provide precise, objective measurements of brain tissue and structures. This AI-powered solution assists physicians, including radiologists, neurologists, and psychiatrists, in the early and differential diagnosis of conditions such as Alzheimer’s disease, Parkinson’s disease, and Multiple Sclerosis.

The AIRAscore software is designed to detect subtle brain volume loss that may not be discernible through visual inspection alone, offering a significant advancement over traditional radiological diagnosis. It generates comprehensive PDF reports that present quantitative data, comparing individual patient brain volumes to an age- and sex-correlated reference population. This clear and easily interpretable format aids in identifying pathological distribution patterns, supporting more accurate diagnoses and enabling individualized treatment strategies.

By providing objective measurement values, AIRAmed aims to improve diagnostic accuracy, facilitate earlier intervention, and ultimately enhance the quality of life for patients affected by neurodegenerative disorders. The technology is based on deep learning and convolutional neural networks, trained on extensive datasets, including pathological cases, to ensure high precision in recognizing disease-specific changes.

Focus Areas

Quantitative neuroradiology AI in radiology early detection of neurodegenerative diseases brain volumetry MRI image analysis differential diagnosis therapy monitoring for Alzheimer's Parkinson's Multiple Sclerosis

Business Intelligence

Key InvestorsCyber Valley AI Incubator
PartnershipsContinental Engineering Services (CES), Harrison.ai, NeoQ, Memory Treatment Centers
TechnologySoftware as a Medical Device (SaMD) running on AIRAmed internal servers (Software as a Service - SaaS), utilizes deep learning and convolutional neural networks (CNNs) for MRI image analysis and brain volumetry.
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Quantitative Neuroradiology & AI in Radiology
AIRAmed specializes in quantitative neuroradiology, leveraging AI to transform subjective visual radiological diagnosis into objective, measurable data. Their flagship product, AIRAscore, analyzes MRI data using artificial intelligence to provide precise volumetric measurements of dedicated brain areas.
Early Detection & Differential Diagnosis of Neurodegenerative Diseases
The company focuses on the early and differential diagnosis of neurodegenerative diseases, including Alzheimer's, Parkinson's, Multiple Sclerosis, frontotemporal dementia, and atypical Parkinson syndromes. AIRAscore detects subtle brain volume loss that is often not visible to the human eye, enabling earlier intervention.
Brain Volumetry & MRI Image Analysis
AIRAmed's core offering is AI-powered brain volumetry, which involves the precise measurement and auto-segmentation of various brain structures (e.g., grey matter, white matter, CSF, hippocampus, cerebellum, brain stem, ventricular systems) from standard T1-weighted MRI scans.
Therapy Monitoring
Beyond diagnosis, AIRAmed's software supports therapy monitoring for neurodegenerative conditions by providing objective, quantifiable data on brain volume changes over time, allowing physicians to assess treatment efficacy and adjust therapies as needed.
Physician Tip

For physicians, AIRAmed's AIRAscore offers several significant advantages:nn* **Enhanced Diagnostic Precision:** Provides objective, quantitative brain volumetry data, complementing visual MRI assessment and improving the accuracy of early and differential diagnoses for neurodegenerative diseases.n* **Facilitates Early Intervention:** Enables the detection of subtle brain atrophy and volume changes that are not discernible by the human eye, allowing for earlier diagnosis and timely initiation of new therapeutic options.n* **Objective Therapy Monitoring:** Offers a quantitative surrogate parameter for disease activity, making it easier to monitor disease progression and the effectiveness of therapies, guiding treatment adjustments.n* **Streamlined Workflow & Comprehensive Reporting:** Delivers detailed evaluation reports within minutes, presented in an easily understandable format similar to a blood laboratory report, which includes comparisons to a large, age- and gender-corrected reference population. This integrates smoothly into existing reporting workflows.n* **Credibility & Data Security:** Backed by cutting-edge university research (e.g., University Hospital of Tu00fcbingen), FDA 510(k) clearance (September 2023), and CE mark (since June 2020), ensuring reliability and adherence to strict data protection standards through pseudonymized and encrypted data transmission.

AIRAmed's software is designed for seamless integration into existing radiology workflows. It processes standard MRI brain scans and provides evaluation reports within minutes. The software can be configured by a hospital's or radiology facility's IT department in less than an hour. Data transmission is encrypted and pseudonymized to ensure maximum data protection. AIRAmed also partners with companies offering professional radiological software solutions for mobile devices, structured reporting, and cloud PACS services, indicating compatibility with various components of a modern radiology infrastructure.

Products by AIRAmed

1 product in the directory

AIRAscore
AIRAmed
Neurology AI
AI-powered software for quantitative brain volumetry from MRI scans to aid in the early and differential diagnosis of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Multiple Sclerosis.

What the Web Says

AIRAmed appears to be a relatively new or niche company, as there is a significant lack of readily available reviews on major platforms like G2, Glassdoor, Capterra, and Reddit. Information from healthcare IT reviewers is also scarce. This makes it difficult to form a comprehensive opinion based on public reviews.

Overall: Mixed

Limitations

  • Lack of public reviews on major platforms (G2, Glassdoor, Capterra)
  • Limited information available from healthcare IT reviewers
  • Difficulty in assessing product quality or employer experience due to review scarcity
  • Potential for limited market penetration or user base if reviews are not present

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers (general search)

Last updated: 2026-07-17

Videos

News, demos, and interviews about AIRAmed.

Loading videos...

Videos load interactively. If none appear, search YouTube for AIRAmed →

View all on YouTube

Press & Coverage

PR Newswire
AIRAmed and Memory Treatment Centers Launch Research Partnership to Study Alzheimer's Disease
AIRAmed has partnered with Memory Treatment Centers to research Alzheimer's disease in cognitively impaired individuals undergoing anti-amyloid therapy, utilizing AIRAmed's AI software, AIRAscore, for precise brain volume measurements.
2024-09
BioWorld
Airamed's AI brain software a 'game-changer' for early Alzheimer's diagnosis
AIRAmed GmbH received U.S. FDA 510(k) clearance for its Airascore software, an AI-powered medical image management system that assesses brain volumetry data from MRI scans for early Alzheimer's disease diagnosis.
2023-10
AIRAmed
AIRAmed: AI in radiology - To Patient site
AIRAmed's AIRAscore software uses artificial intelligence to analyze MRI data and provide objective brain volumetry measurements, aiding physicians in the early and differential diagnosis of neurodegenerative diseases.
unknown
AIRAmed
Publications & Scientific Evidence - To Doctor site - AIRAmed
AIRAmed highlights various studies demonstrating the clinical benefit and diagnostic value of AIRAscore for automated tissue segmentation and brain volume reduction determination in neurodegenerative diseases.
unknown
accessdata.fda.gov
510(k) Premarket Notification - FDA (K223180)
The FDA reviewed AIRAmed GmbH's 510(k) premarket notification for AIRAscore, determining it substantially equivalent to legally marketed predicate devices for its intended use as a medical image management and processing system.
2023-08
BioWorld
AI med-tech Airs Medical raises $20M in series C | BioWorld
While this article primarily focuses on 'Airs Medical,' it mentions that Tuebingen, Germany-based Airamed GmbH also received 510(k) clearance from the U.S. FDA in October 2023 for its AI-based brain software, Airascore, for early Alzheimer's diagnosis.
2024-07
AIRS Medical Inc.
AIRS Medical Secures $20M in Series C Funding to Advance AI-Powered Preventive Healthcare Solutions
AIRS Medical, a company with a similar name, announced the completion of its Series C funding round, securing $20 million to advance its AI and robotics for healthcare applications, particularly its SwiftMRu2122 product.
2024-07

Frequently Asked Questions

AIRAmed's flagship product, AIRAscore, is an AI-powered software designed for quantitative brain volumetry, analyzing high-resolution T1-weighted MRI images. It employs deep learning algorithms to precisely measure the volume of various brain structures, providing objective data to complement visual assessment in neuroradiology.
AIRAscore assists physicians by comparing a patient's individual brain volumes against a large, age- and gender-adjusted reference population, enabling the identification of subtle volumetric changes associated with neurodegeneration. This supports early detection, helps differentiate between various forms of dementia and movement disorders, and allows for objective monitoring of disease progression and treatment efficacy for conditions such as Alzheimer's, Parkinson's, and Multiple Sclerosis.
AIRAmed's AIRAscore software received U.S. FDA 510(k) clearance in September 2023, having been commercially available in Europe for four years prior. The software operates with data hosted in Germany, and patient data transmission adheres to strict data protection regulations, ensuring pseudonymization to safeguard patient identity and privacy.
AIRAscore is designed for straightforward integration, described as being 'extremely affordable' and configurable by a hospital's or radiology facility's IT department in under an hour. It processes standard T1-weighted MRI brain scans and delivers comprehensive evaluation reports, including auto-segmentation of various brain tissues, within as little as five minutes, streamlining the image analysis workflow.
While specific pricing details for AIRAscore are not publicly disclosed, the software is noted for being 'extremely affordable' and easy to implement. AIRAmed offers customer support via phone at +49 (0) 7071 / 53 933 40 and email at [email protected], and can also help connect interested parties with clinics already utilizing their evaluation capabilities.
Founded in 2019 and headquartered in Tu00fcbingen, Germany, AIRAmed is a privately held company backed by the Cyber Valley AI Incubator and is actively generating revenue. They maintain strategic partnerships with sales and cooperation entities like mbits and NeoQ, collaborate with research institutions such as the University Hospital Tu00fcbingen, and recently joined Harrison.ai's Open Platform, enhancing their market presence and innovation.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]

Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]

Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.